Urinary mRNA Profiles in Diabetic Nephropathy
Author Information
Author(s): Zheng Min Lv, Lin-Li Ni, Jie Ni, Hai-Feng Li, Qing Ma, Kun-Ling Liu, Bi-Cheng Liu
Primary Institution: Institute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine, Nanjing, China
Hypothesis
The urinary mRNA profile of podocyte-associated molecules may provide important clinical insight into the different stages of diabetic nephropathy.
Conclusion
The urinary mRNA profiles of synaptopodin, podocalyxin, CD2-AP, α-actin4, and podocin increase with the progression of diabetic nephropathy, suggesting they may serve as useful biomarkers.
Supporting Evidence
- The urinary mRNA levels of all genes studied were significantly higher in the diabetic nephropathy group compared with controls.
- mRNA levels increased with diabetic nephropathy progression.
- Urinary mRNA levels positively correlated with urinary albumin excretion and blood urea nitrogen.
Takeaway
This study found that certain molecules in urine can help doctors understand how bad someone's kidney disease is if they have diabetes.
Methodology
Patients with diabetic nephropathy and healthy controls were studied, and urinary mRNA levels of specific podocyte-associated genes were quantified using real-time PCR.
Potential Biases
Potential biases may arise from the selection of participants and the reliance on urinary mRNA as a biomarker.
Limitations
The study was limited to a specific population and may not be generalizable to all diabetic nephropathy patients.
Participant Demographics
51 patients with type 2 diabetic nephropathy and 13 healthy controls, with varying ages and sex distributions.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% confidence interval, 0.623 to 0.883
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website